+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Third Party Logistics Market - Global Forecast 2026-2032- Product Image
Biopharmaceutical Third Party Logistics Market - Global Forecast 2026-2032- Product Image
New

Biopharmaceutical Third Party Logistics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010883
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biopharmaceutical third-party logistics market is experiencing significant evolution as new therapies, regulatory changes, and technological advancements redefine expectations for global supply chain management.

Market Snapshot

The Biopharmaceutical Third Party Logistics Market is projected to grow from USD 140.03 billion in 2025 to USD 161.04 billion in 2026 and is forecast to reach USD 384.23 billion by 2032, representing a compound annual growth rate (CAGR) of 15.51%. This expansion reflects escalating demand for cold chain integrity, specialized handling, and advanced supply network visibility as product complexity rises across biological and gene-based modalities. Increased regulatory focus and evolving patient delivery models further accelerate the need for strategic logistics partnerships.

Scope & Segmentation

  • Service Types: Distribution Management, Packaging & Labeling, Transportation, Warehousing
  • Packaging & Labeling: Active Packaging (Controlled Atmosphere Packaging, Refrigerated Containers), Labeling Services, Passive Packaging
  • Transportation Modes: Air Transport (Express, Standard), Rail Transport, Road Transport, Sea Transport
  • Warehousing Categories: Ambient Storage, Cold Storage
  • Temperature Ranges: Ambient, Chilled (Monitored, Standard), Controlled Room Temperature (Monitored, Standard), Frozen (Standard, Ultra Frozen)
  • Mode Of Transportation: Air Freight (Express, Standard), Rail Freight, Road Transport (Full Truck Load, Less Than Truck Load), Sea Freight (Full Container Load, Less Than Container Load)
  • End Users: Biopharmaceutical Manufacturers, Contract Manufacturing and Research Organizations, Diagnostic Laboratories, Hospitals & Clinics (Community, Research)
  • Product Types: Cell Therapies (Dendritic Cell, Stem Cell), Gene Therapies, Monoclonal Antibodies, Recombinant Proteins, Vaccines (Inactivated, Live Attenuated)
  • Packaging Types: Active (Refrigerated Containers, Temperature Controlled Shippers), Passive (Insulated Boxes, Thermal Blankets)
  • Regions: Americas, Europe Middle East & Africa, Asia-Pacific

Key Takeaways

  • Rising product complexity and patient-focused supply models require logistics partners with advanced cold chain and clinical support capabilities.
  • Regulatory scrutiny is intensifying, pushing for improved traceability, standardized validation, and audit-ready data management throughout the logistics life cycle.
  • Technology advancements such as active packaging and telemetry-enabled monitoring enable real-time shipment visibility and dynamic risk mitigation, reducing spoilage and operational disruptions.
  • Strategic vendor selection increasingly prioritizes cross-functional collaboration between manufacturing, clinical, quality, and commercial teams to ensure alignment with therapeutic and market requirements.
  • Specialized assets, digital orchestration, and demonstrated experience with high-value biologics now drive competitive differentiation and long-term supplier relationships.

Tariff Impact: U.S. Policy Changes and Network Adaptation

The 2025 United States tariff adjustments are influencing cold chain route selection, modal optimization, and contract structures across the sector. Organizations are rebalancing between direct air corridors, intermodal solutions, and regional hubs for cost efficiency while maintaining quality standards. This shift prompts increased collaboration among procurement, customs, and logistics stakeholders, as well as a focus on duty management and contingency planning. Decision-makers are employing scenario analysis, revising service agreements, leveraging bonded warehousing, and exploring nearshoring to mitigate tariff volatility and protect biologic product stability.

Methodology & Data Sources

This report is built on a mixed-methods research approach including qualitative interviews with supply chain executives, regulatory, and packaging experts, combined with capability mapping and scenario-based analysis. Primary data are triangulated with secondary documentation—such as industry guidance and vendor technical specifications—to ensure accuracy and relevance. The analysis emphasizes validated processes, audit outcomes, and performance reliability.

Why This Report Matters

  • Empowers executive stakeholders to benchmark logistics sourcing, network design, and risk management strategies for complex biologics.
  • Clarifies the impact of regulatory, product, and tariff shifts, guiding resilient investment in validated cold chain infrastructure and digital solutions.
  • Delivers actionable insights for aligning operations, compliance, and commercial goals in a rapidly transforming market environment.

Conclusion

Meeting future demands in biopharmaceutical logistics requires alignment between technology, capability-based sourcing, and collaborative strategic planning. Organizations investing in validated and adaptable cold chain systems are positioned to protect product quality, reduce risk, and ensure timely patient access.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biopharmaceutical Third Party Logistics Market, by Product Type
8.1. Cell Therapies
8.1.1. Dendritic Cell Therapies
8.1.2. Stem Cell Therapies
8.2. Gene Therapies
8.3. Monoclonal Antibodies
8.4. Recombinant Proteins
8.5. Vaccines
8.5.1. Inactivated
8.5.2. Live Attenuated
9. Biopharmaceutical Third Party Logistics Market, by Service Type
9.1. Distribution Management
9.2. Packaging & Labeling
9.2.1. Active Packaging
9.2.1.1. Controlled Atmosphere Packaging
9.2.1.2. Refrigerated Containers
9.2.2. Labeling Services
9.2.3. Passive Packaging
9.3. Transportation
9.3.1. Air Transport
9.3.1.1. Express Air
9.3.1.2. Standard Air
9.3.2. Rail Transport
9.3.3. Road Transport
9.3.4. Sea Transport
9.4. Warehousing
9.4.1. Ambient Storage Warehousing
9.4.2. Cold Storage Warehousing
10. Biopharmaceutical Third Party Logistics Market, by Temperature Range
10.1. Ambient
10.2. Chilled
10.2.1. Monitored Chilled
10.2.2. Standard Chilled
10.3. Controlled Room Temperature
10.3.1. Monitored Controlled Room Temperature
10.3.2. Standard Controlled Room Temperature
10.4. Frozen
10.4.1. Standard Frozen
10.4.2. Ultra Frozen
11. Biopharmaceutical Third Party Logistics Market, by Mode Of Transportation
11.1. Air Freight
11.1.1. Express Air
11.1.2. Standard Air
11.2. Rail Freight
11.3. Road Transport
11.3.1. Full Truck Load
11.3.2. Less Than Truck Load
11.4. Sea Freight
11.4.1. Full Container Load
11.4.2. Less Than Container Load
12. Biopharmaceutical Third Party Logistics Market, by Packaging Type
12.1. Active Packaging
12.1.1. Refrigerated Containers
12.1.2. Temperature Controlled Shippers
12.2. Passive Packaging
12.2.1. Insulated Boxes
12.2.2. Thermal Blankets
13. Biopharmaceutical Third Party Logistics Market, by End User
13.1. Biopharmaceutical Manufacturers
13.2. Contract Manufacturing Organizations
13.3. Contract Research Organizations
13.4. Diagnostic Laboratories
13.5. Hospitals & Clinics
13.5.1. Community Hospitals
13.5.2. Research Hospitals
14. Biopharmaceutical Third Party Logistics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Biopharmaceutical Third Party Logistics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Biopharmaceutical Third Party Logistics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Biopharmaceutical Third Party Logistics Market
18. China Biopharmaceutical Third Party Logistics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Agility Public Warehousing Company K.S.C.P.
19.6. Bolloré SE
19.7. C.H. Robinson Worldwide, Inc.
19.8. Cardinal Health, Inc.
19.9. Cencora, Inc.
19.10. CEVA Logistics AG
19.11. Cryoport, Inc.
19.12. DB Schenker Logistics Germany AG & Co. KG
19.13. Deutsche Post AG
19.14. DSV Panalpina A/S
19.15. EVERSANA Life Science Services LLC
19.16. Expeditors International of Washington, Inc.
19.17. FedEx Corporation
19.18. KLN Logistics Group Limited
19.19. Kuehne + Nagel International AG
19.20. LOGISTEED, Ltd.
19.21. McKesson Corporation
19.22. NIPPON EXPRESS HOLDINGS, INC.
19.23. SF Holding Co., Ltd.
19.24. Thermo Fisher Scientific Inc.
19.25. United Parcel Service, Inc.
19.26. XPO, Inc.
List of Figures
FIGURE 1. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STEM CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STEM CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY GENE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY GENE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DISTRIBUTION MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DISTRIBUTION MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DISTRIBUTION MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ATMOSPHERE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ATMOSPHERE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ATMOSPHERE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LABELING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LABELING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LABELING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT STORAGE WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT STORAGE WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT STORAGE WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD STORAGE WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD STORAGE WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD STORAGE WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CHILLED, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CHILLED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CHILLED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CHILLED, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CHILLED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CHILLED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CONTROLLED ROOM TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CONTROLLED ROOM TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CONTROLLED ROOM TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CONTROLLED ROOM TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD FROZEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD FROZEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ULTRA FROZEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ULTRA FROZEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ULTRA FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL FREIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL TRUCK LOAD, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL TRUCK LOAD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL TRUCK LOAD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN TRUCK LOAD, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN TRUCK LOAD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN TRUCK LOAD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL CONTAINER LOAD, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL CONTAINER LOAD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL CONTAINER LOAD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN CONTAINER LOAD, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN CONTAINER LOAD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN CONTAINER LOAD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED SHIPPERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED SHIPPERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED SHIPPERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INSULATED BOXES, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INSULATED BOXES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INSULATED BOXES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY THERMAL BLANKETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY THERMAL BLANKETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY THERMAL BLANKETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RESEARCH HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RESEARCH HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 222. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 223. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA BIOPHARMACEUTICAL THIRD PARTY

Companies Mentioned

The key companies profiled in this Biopharmaceutical Third Party Logistics market report include:
  • Agility Public Warehousing Company K.S.C.P.
  • Bolloré SE
  • C.H. Robinson Worldwide, Inc.
  • Cardinal Health, Inc.
  • Cencora, Inc.
  • CEVA Logistics AG
  • Cryoport, Inc.
  • DB Schenker Logistics Germany AG & Co. KG
  • Deutsche Post AG
  • DSV Panalpina A/S
  • EVERSANA Life Science Services LLC
  • Expeditors International of Washington, Inc.
  • FedEx Corporation
  • KLN Logistics Group Limited
  • Kuehne + Nagel International AG
  • LOGISTEED, Ltd.
  • McKesson Corporation
  • NIPPON EXPRESS HOLDINGS, INC.
  • SF Holding Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • XPO, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 161.04 Billion
Forecasted Market Value ( USD ) by 2032 $ 384.23 Billion
Compound Annual Growth Rate15.5%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Biopharmaceutical Cold Chain Third Party Logistics Market Forecast to 2033 - Product Image

Biopharmaceutical Cold Chain Third Party Logistics Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2026-2033 - Product Image

Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Biopharmaceutical Third-Party Logistics Market Report 2025 - Product Image

Biopharmaceutical Third-Party Logistics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biopharmaceutical Cold Chain Third Party Logistics Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Biopharmaceutical Cold Chain Third Party Logistics Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 93 Pages
  • Global
From
Biopharmaceutical Third-Party Logistics Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Biopharmaceutical Third-Party Logistics Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Biopharmaceutical Third Party Logistics Market

Biopharmaceutical Third Party Logistics (3PL) is a specialized form of logistics services that focuses on the storage, transportation, and distribution of biopharmaceutical products. These products are typically temperature-sensitive and require specialized handling and storage conditions. 3PL providers offer a range of services, including temperature-controlled storage, order fulfillment, and distribution. They also provide value-added services such as inventory management, packaging, and labeling. 3PL providers are an important part of the biopharmaceutical supply chain, as they help ensure that products are delivered safely and on time. They also help reduce costs and improve efficiency by providing a range of services that are tailored to the needs of the biopharmaceutical industry. Some of the leading companies in the biopharmaceutical 3PL market include AmerisourceBergen, Cardinal Health, McKesson, FedEx, UPS, and DHL. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.